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Summary
 Aim The aim of this study is to evaluate the inﬂ uence of high dose rate (HDR) brach-
ytherapy source step size, source dwell position, dose prescription depth, dose 
speciﬁ cation points and optimization technique on dose distribution around 
Microselectron HDR brachytherapy vaginal cylinders and to evaluate the inﬂ u-
ence of distal dwell position and optimization technique on rectal and bladder 
dose of patients treated for vaginal cuff irradiation.
 Materials/Methods Orthogonal radiographs of vaginal cylinders of diameter 2.0, 2.5, 3.0 and 3.5cm 
form the basis of the study. Dose distribution using the PLATO brachytherapy 
treatment planning system (version 14.1) was generated. Two different HDR cyl-
inder models, namely the non-curved dome model (NCDM) and curved dome 
model (CDM), were studied. To evaluate bladder and rectum dose in the patients 
NCDM was used.
 Results CDM gives more uniform dose distribution around the cylinder than NCDM. Dose 
prescription at 5mm depth from the surface results in very high dose to apex and 
dome as compared with the surface dose prescription. Dose prescription depth and 
dwell positions inﬂ uence the length of prescription isodose. Optimization meth-
od and dwell positions affect the bladder and rectal dose of the studied patients.
 Conclusions Uniform dose distribution can be obtained for HDR vaginal cylinders by appro-
priately selecting dose speciﬁ cation points and optimization method. Dose distri-
bution can be conﬁ gured to provide a uniform dose on the surface, if the apex 
and curved surface of the cylinder are considered for dose speciﬁ cation and op-
timization. Appropriate HDR parameters are identiﬁ ed to minimize the dose to 
the apex of the vaginal cylinder, essential to reduce the dose to overlying small 
bowel and reduce the dose to rectum and bladder.
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BACKGROUND
Endometrial carcinoma is the most common 
malignancy arising in the female genital tract. 
External beam radiotherapy with or without 
brachytherapy is an integral component in 
the postoperative adjuvant therapy and in the 
management of inoperable or recurrent en-
dometrial cancer. The purpose of intravagi-
nal brachytherapy is to prevent recurrences at 
the vaginal vault and in the inner part of the 
vagina. Vaginal cylinders are often used to de-
liver brachytherapy dose to the vaginal apex 
and to the upper vagina or to the entire vagi-
nal surface.
The organs at risk (OAR) in the vaginal cuff irra-
diation are the rectum, bladder and small bow-
el. Anatomically the bladder lies anteriorly and 
the rectum posteriorly to the vaginal cylinder 
placed in the vaginal cavity. The small bowel lies 
in proximity to the apex and curved dome of the 
vaginal cylinder.
The most important risk factor in vaginal cuff 
irradiation is the mucosal surface dose, the dose 
gradient in the mucosa, or the dose at the level 
of the connective tissue. Study shows [1] that 
choosing the dose prescription depth accord-
ing to mucosal thickness can minimize the late 
radiation reaction. It is reported in the liter-
ature that irradiation of the entire vagina re-
sults in increased rectal [2] toxicity. Study indi-
cates an association between reference isodose 
length and vaginal shortening [3]. Symptoms 
of acute radiation for small bowel depend on 
dose per fraction and amount of small bowel 
in the treatment volume [4]. Hence reducing 
the dose to the small bowel assumes impor-
tance in the treatment of vaginal cuff irradi-
ation. Comparison of dose distribution be-
tween low dose rate and high dose rate vaginal 
cylinders has been studied [5]. Modern step-
ping source high dose rate brachytherapy sys-
tem and optimization techniques offer scope 
to customize dose distribution according to 
clinical requirement. Though the American 
Brachytherapy Society [6] has given recom-
mendations for HDR brachytherapy for Ca. of 
the endometrium in the year 2000, a recent 
survey in the year 2005 [7] indicated that the 
majority of HDR vaginal brachytherapy users 
are using different dose fractionation [8] and 
dose prescription methods and are not includ-
ing dose points at the curved end in their plan 
optimization.
AIM
The aim of the work is to evaluate the inﬂ uence 
of Microselectron HDR source step size, dwell po-
sition, optimization technique, dose prescription 
depth and dose speciﬁ cation points on dose to 
apex and dome points of the vaginal cylinders. 
The inﬂ uence of distal dwell position and opti-
mization technique on rectal and bladder dose 
is also evaluated for 20 patients who had under-
gone vaginal cuff irradiation.
MATERIALS AND METHODS 
The Microselectron HDR vaginal cylinder set is 
constructed with a series of disk-shaped pieces 
assembled over a central tandem. Each disk is 
25mm in length. The apical piece is dome shaped. 
Vaginal cylinders of diameter 2.0, 2.5, 3.0 and 
3.5cm were taken for the study. Vaginal cylinders 
were placed on the simulator couch and orthog-
onal radiographs were acquired using the isocen-
tric technique. These radiographs were used for 
applicator reconstruction.
Two different HDR cylinder models, namely the 
non-curved dome model (NCDM) and curved 
dome model (CDM), were studied. NCDM as-
sumes that the applicator is cylindrical in shape 
and without a curved dome. In this model the 
dose speciﬁ cation points are placed lateral to 
each source dwell position on the surface of the 
cylinder or at 5mm from the surface of the cyl-
inder. It is the most commonly used model in 
routine brachytherapy planning due to its sim-
plicity. CDM accounts for the dome shape of 
the cylindrical HDR applicator. In this model 
the dose speciﬁ cation points are placed on the 
lateral and curved dome surface of the applica-
tor. Schematic diagrams of CDM and NCDM are 
shown in Figures 1 and 2.
Source dwell positions are activated from the 
distal to proximal end (where the applicator is 
connected with the transfer tube) of the appli-
cator for an intended treatment length of 4cm. 
The nearest dwell position is approximately 6mm 
from the apex. Optimized dose distribution (for 
100cGy dose prescription) for CDM and NCDM 
of a vaginal cylinder with source step size of 
2.5mm and 5mm, for dose point optimization 
(DPO) and geometric optimization (GO), with 
and without considering apex for dose speciﬁ -
cation, were generated. Optimized dose distri-
bution for CDM was generated for surface pre-
scription only.
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For patients who had undergone HDR vaginal 
cuff irradiation, a cylinder that ﬁ t comfortably 
in the vagina of the patient was selected and 
used. Numbers of cylinders and dwell positions 
are chosen according to the intended length of 
the vagina to be treated. To evaluate the blad-
der and rectal dose, the organs are identiﬁ ed 
on the orthogonal radiograph as described. The 
bladder is visualized by placing 7cc of contrast 
medium into the Foley catheter balloon. The 
bladder point is marked on the radiograph as 
per the guidelines of ICRU 38 [9]. On the an-
terior view of the radiograph the bladder ref-
erence point is taken at the centre of the bal-
loon. In the lateral view, the reference point 
is chosen on an anterior-posterior line drawn 
through the Foley catheter balloon centre at 
the posterior surface. A standard rectal mark-
er is inserted through the anal canal to identify 
the rectal position. Four rectal reference points 
spread uniformly over the treatment length are 
marked on the anterior and lateral radiographs. 
NCDM, the widely used vaginal cylinder mod-
el in brachytherapy planning, alone is consid-
ered for dose computation. Source dwell posi-
tions are 5mm apart. Dose points are placed at 
5mm from the surface of the cylinder for pre-
scription and optimization. Inﬂ uence of distal 
dwell position on rectal and bladder dose is eval-
uated for DPO and GO.
PLATO brachytherapy treatment planning sys-
tem (version 14.1) with anisotropy calculations 
is used for dose computation.
RESULTS
Dose to apex, dome points, dose points, prescrip-
tion isodose covering volume and total treatment 
time are evaluated for CDM and NCDM.
Curved Dome Model
Dose to apex is generally higher with geomet-
ric optimization than with dose point optimi-
zation.
Source Step Size: Changing source step size from 
2.5mm to 5mm increases the dose to apex. The 
increase in dose to apex is higher when the mode 
of optimization is GO as compared to DPO (re-
fer Tables 1–4).
Figure 1. Curved Dome Model (CDM). z Dome Points. 8 Dose 
points.  Apex. Figure 2. Non-Curved Dome Model (NCDM). 8 Dose points.  Apex.
Rep Pract Oncol Radiother, 2008; 13(1): 35-48 Sivakumar SS et al – Vaginal cylinder optimization
37
Dose Specification/Optimization Points: 
Considering the apex point for dose speciﬁ ca-
tion reduces dose to apex in the case of GO and 
increases with DPO.
Non-Curved Dome Model
Source Step Size: Dose to apex increases when 
source step size is changed from 2.5mm to 5mm. 
Curved Dome Model
Step size 
(mm)
Dose at 
apex (cGy)
Dose at
dome points (cGy)
Dose on
dose points* (cGy)
Treatment time 
for 100cGy
Prescription 
isodose volume (cc)
For
optimization
Dose point optimization – dose prescription on the surface of the cylinder
2.5 84.7 107.8,101.1,98.5 103.1,101.5,93.3 163.4 15.3
Apex not considered
5.0 90.8 108.0,104.4, 97.0 103.9,103.5,91.5 164.3 15.3
2.5 90.0 111.8, 97.3, 97.6 102.0, 99.5, 93.2 164.0 15.3
Apex considered
5.0 93.5 111.1, 96.8, 95.2 103.3,102.9,91.8 163.4 15.2
Geometric optimization – dose prescription on the surface of the cylinder
2.5 94.0 109.7,101.9,94.1 103.8,101.8, 96.1 158.3 14.9
Apex not considered
5.0 114.0 130.9, 109.7,95.9 101.6,101.4,99.9 161.1 15.1
2.5 92.3 106.9, 92.6, 94.6 104.4,101.4,96.6 159.1 14.9
Apex considered
5.0 112.8 124.7, 99.1, 94.8 100.4,100.3,98.7 159.4 14.9
Non-Curved Dome Model
Dose point optimization – dose prescription on the surface of the cylinder
2.5 122.0 146.3,123.5,102.8 103.7,102.3,101.5 169.0 16.0
Apex not considered
5.0 127.9 146.5,120.4,102.2 103.8,103.4,100.1 168.5 15.9
2.5 103.5 127.5,117.3,102.2 103.8,103.7,98.9 166.9 15.6
Apex considered
5.0 105.2 125.2,112.3,100.8 105.2,102.7,86.3 167.1 15.5
Dose point optimization – dose prescription at 5mm
2.5 208.8 294.0, 223.6,190.2 104.1,102.8,98.8 292.8 37.6
Apex not considered
5.0 225.1 294.4, 213.7, 182.4 103.1,100.9,96.6 291.0 37.5
2.5 106.2 180.4, 178.3, 178.0 104.0, 98.9, 91.3 283.6 35.4
Apex considered
5.0 112.1 168.8, 162.1, 159.1 99.3, 93.1, 85.2 278.2 35.2
Geometric optimization – dose prescription on the surface of the cylinder
2.5 104.8 111.5, 103.6, 95.6 102.4, 97.6, 90.4 160.2 15.1
Apex not considered
5.0 116.9 134.3, 112.5, 98.3 103.5,103.1,95.1 165.3 15.7
2.5 104.4 111.0, 103.2, 95.2 102.0, 97.2, 89.9 160.2 15.1
Apex considered
5.0 116.2 133.3, 111.7, 97.6 103.3,102.8,99.2 164.2 15.3
 Geometric optimization – dose prescription at 5mm
2.5 159.2 221.5, 177.4,164.3 100.4, 95.2,88.6 276.8 34.9
Apex not considered
5.0 205.1 264.9,192.7,168.9 100.9, 97.1, 91.7 283.8 36.3
2.5 154.0 214.5, 171.7, 159.1 97.2, 92.2, 85.8 267.9 33.2
Apex considered
5.0 193.7 250.3, 182.1, 159.6 95.4, 91.7, 86.6 268.2 33.0
Table 1. Evaluated parameters for vaginal cylinder of 2.0cm diameter.
Dose Point* – Dose specifi cation points placed on the lateral sides of the vaginal cylinder.
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The increase in dose to apex is higher when mode 
of optimization is GO as compared to DPO (see 
Tabless 1–4).
Prescription Depth: Dose prescription at 5mm 
from the surface of the cylinder results in very 
high dose to apex and curved portion of the 
Dose Point * – Dose specifi cation points placed on the lateral sides of the vaginal cylinder.
Table 2. Evaluated parameters for vaginal cylinder of 2.5cm diameter.
Curved Dome Model
Step size 
(mm)
Dose at 
apex (cGy)
Dose at
dome points (cGy)
Dose on
dose points* (cGy)
Treatment time 
for 100cGy
Prescription 
isodose volume (cc)
For
optimization
Dose point optimization – dose prescription on the surface of the cylinder
2.5 85.8 104.3,101.1,96.7 102.1,101.4, 95.6 200.9 22.9
Apex not considered
5.0 92.0 107.6,100.2,94.6 104.0,102.8, 99.2 200.4 23.0
2.5 91.0 112.3,104.3,96.8 103.9,103.7,100.8 201.0 23.1
Apex considered
5.0 95.5 113.9,102.9,94.9 104.0, 102.8, 99.2 200.3 23.0
Geometric optimization – dose prescription on the surface of the cylinder
2.5 106.9 130.9,111.7,97.8 102.5,100.1, 95.1 192.8 21.6
Apex not considered
5.0 133.7 156.1,123.5,102.5 97.9, 96.8, 94.8 192.4 21.6
2.5 106.4 130.5,111.4,97.5 100.9, 98.6, 95.1 191.6 21.6
Apex considered
5.0 131.4 153.5,121.4,100.8 94.7, 96.8, 94.8 190.1 21.0
Non-Curved Dome Model
dose point optimization – dose prescription on the surface of the cylinder
2.5 148.8 181.3,147.5,121.2 103.9,103.4, 99.8 212.2 24.8
Apex not considered
5.0 156.8 183.8,144.9,118.7 104.1,102.7, 98.5 211.5 24.7
2.5 104.5 136.6,123.9,110.7 105.7,101.6, 93.7 206.1 24.0
Apex considered
5.0 109.6 134.9,117.8,105.1 106.1,105.9, 96.7 205.3 23.9
Dose point optimization – dose prescription at 5 mm 
2.5 239.6 296.3, 246.0,204.5 103.3,101.7,98.0 343.3 51.3
Apex not considered
5.0 243.9 287.2,228.7,188.8 101.7, 98.8, 94.3 337.0 50.5
2.5 106.6 164.8,159.2,158.9 101.3, 95.9, 88.8 328.9 48.4
Apex considered
5.0 118.2 146.9, 146.1,143.7 96.1, 89.8, 82.3 319.1 46.7
Geometric optimization – dose prescription on the surface of the cylinder
2.5 111.8 136.6,116.6,102.1 100.9, 95.7, 88.7 200.9 20.1
Apex not considered
5.0 143.1 166.9,132.0,109.6 101.4, 97.9, 92.6 206.6 24.0
2.5 111.0 134.0,114.3,100.0 98.8, 93.8, 86.9 196.9 22.9
Apex considered
5.0 139.5 163.0,128.9,107.1 98.5, 96.7, 91.5 201.8 23.1
Geometric Optimization – Dose Prescription at 5mm
2.5 179.6 219.8,187.6,164.2 99.8, 94.8, 88.7 323.1 47.5
Apex not considered
5.0 229.0 267.1,211.2,175.4 100.3, 96.3, 91.0 330.8 49.2
2.5 172.1 210.6,179.6,157.2 95.6, 90.8, 84.9 309.2 44.9
Apex considered
5.0 213.7 249.3,197.2,163.7 93.6, 89.9, 84.9 308.8 44.3
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cylinder as compared with the surface dose pre-
scription. Table 5 shows the percentage increase 
in dose to apex when dose prescription changed 
from surface to 5mm depth.
Prescription Isodose Line Length: Dose prescrip-
tion depth and diameter of the cylinder are the 
two major parameters inﬂ uencing the length 
of the prescription isodose and treatment time. 
Curved Dome Model
Step size 
(mm)
Dose at 
apex (cGy)
Dose at
dome points (cGy)
Dose on
dose points* (cGy)
Treatment time
for 100cGy
Prescription
isodose volume ( cc)
For
optimization
Dose point optimization – dose prescription on the surface of the cylinder
2.5 87.0 106.9,105.1,103.9 101.0,94.6,86.0 272.7 32.9
Apex not considered
5.0 94.7 110.9,102.0,100.8 108.1,102.6,90.2 269.5 32.4
2.5 92.0 111.8,107.3,107.1 100.4, 94.0, 85.7 273.0 33.1
Apex considered
5.0 98.2 114.1,103.1,101.1 107.8, 102.2,89.9 269.5 32.4
Geometric pptimization – dose prescription on the surface of the cylinder
2.5 133.3 148.7,116.3,104.9 98.7, 94.9, 90.0 257.4 30.5
Apex not considered
5.0 166.9 177.8,128.2,109.5 94.1, 91.5, 85.6 257.2 30.6
2.5 132.3 152.7,120.2,107.9 96.9, 93.8, 88.4 252.7 29.7
Apex considered
5.0 159.6 169.9,122.5,114.7 90.8, 87.5, 81.8 247.8 28.7
Non-Nurved Dome Model
Dose point optimization – dose prescription on the surface of the cylinder
2.5 194.0 216.4,163.5,139.3 100.0, 94.8, 88.2 293.8 36.6
Apex not considered
5.0 203.0 218.0,157.8,133.8 104.5,103.5,101.1 292.9 36.5
2.5 105.5 131.9,123.0,118.9 103.9, 99.1, 91.7 285.6 35.4
Apex considered
5.0 111.7 127.9,111.3,106.5 107.3,103.1,92.2 280.5 34.5
Dose point optimization – dose prescription at 5mm
2.5 280.3 333.8, 253.3, 215.7 102.2,100.2,96.6 447.3 68.9
Apex not considered
5.0 297.9 302.1,222.7,191.9 100.6, 96.9, 92.2 433.7 66.3
2.5 117.0 159.7,157.8,155.1 98.6, 93.1, 86.4 421.1 63.4
Apex considered
5.0 122.7 140.7,136.8,132.8 93.8, 87.2, 79.9 410.0 61.0
Geometric pptimization – dose prescription on the surface of the cylinder
2.5 147.2 163.7,128.9,115.7 100.0, 95.0, 88.4 277.8 34.1
Apex Not considered
5.0 190.4 202.7,146.1,124.8 107.3, 104.3, 97.6 286.0 35.7
2.5 143.6 159.7,125.7,112.8 101.4, 97.6, 92.5 271.9 33.0
Apex considered
5.0 175.1 186.4,134.4,114.8 98.7, 94.9, 89.9 273.0 33.1
Geometric pptimization – dose prescription at 5mm
2.5 223.1 247.9,195.3,175.3 99.6, 94.8, 89.1 422.0 64.3
Apex Not considered
5.0 278.6 302.9,218.4,186.5 99.9, 95.9, 91.0 431.5 66.3
2.5 208.8 232.1,182.8,164.1 93.2, 88.7, 83.4 395.2 57.9
Apex considered
5.0 258.0 274.8,198.1,169.2 90.6, 87.1, 82.6 391.5 57.1
Table 3. Evaluated parameters for vaginal cylinder of 3.0 cm diameter.
Dose Point* – Dose specifi cation points placed on the lateral sides of the vaginal cylinder.
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Source loading length of 4cm gives a prescrip-
tion isodose length of more than 5cm depending 
on the chosen HDR parameters. Table 6 shows 
the length of prescription isodose line for both 
modes of optimization for the studied vaginal 
cylinders.
Curved Dome Model
Step size 
(mm)
Dose at 
apex (cGy)
Dose at
dome points (cGy)
Dose on
dose points* (cGy)
Treatment time 
for 100cGy
Prescription 
isodose volume (cc)
For
optimization
Dose point optimization – dose prescription on the surface of the cylinder
2.5 90.0 103.1, 99.3, 97.7 102.0,100.6, 98.1 300.1 43.5
Apex not considered
5.0 98.8 107.8, 95.8, 92.9 102.9, 99.8, 95.8 295.3 43.2
2.5 95.1 109.7, 99.4, 96.1 101.7,100.0,96.9 300.1 43.6
Apex considered
5.0 100.2 108.3, 95.9, 92.8 102.6, 99.5, 95.5 295.6 42.9
Geometric pptimization – dose prescription on the surface of the cylinder
2.5 154.9 165.2,118.9,101.5 100.6, 99.5, 97.7 288.8 41.2
Apex not considered
5.0 172.6 175.7, 123.8, 100.8 97.0, 96.4, 95.1 295.1 41.5
2.5 149.1 158.9, 114.4, 97.7 97.6, 96.6, 94.8 279.9 39.2
Apex considered
5.0 162.2 169.4, 116.4, 94.8 92.1, 91.5, 90.8 273.9 38.0
Non-Curved Dome Model
Dose point optimization – dose prescription on the surface of the cylinder
2.5 213.9 220.6,156.2,117.1 103.4,101.2,98.1 335.2 50.8
Apex not considered
5.0 216.5 226.7,146.2,114.3 101.8, 98.9, 94.4 329.1 49.9
2.5 107.6 141.9,124.2,106.1 101.3,96.1,89.1 322.1 48.0
Apex considered
5.0 113.1 123.9,113.8,106.2 96.4, 90.2, 82.9 312.7 46.3
Dose point optimization – dose prescription at 5mm
2.5 294.0 312.7, 300.5, 223.6 98.6, 94.9, 90.0 483.6 89.6
Apex not considered
5.0 305.0 316.4, 306.5, 227.0 95.9, 91.0, 85.4 467.5 84.2
2.5 117.4 170.3, 162.7, 157.9 90.6, 84.2, 77.4 449.4 79.0
Apex considered
5.0 124.6 145.3, 144.9, 141.2 85.8, 79.0, 72.1 444.3 77.4
Geometric optimization – dose prescription on the surface of the cylinder
2.5 172.8 175.0,127.2,113.7 96.3, 95.5, 91.5 315.3 47.1
Apex not considered
5.0 191.4 196.4,137.3,111.8 100.3, 96.3, 85.8 323.1 48.8
2.5 161.3 169.3,124.9,110.9 99.9, 94.9, 88.7 304.0 44.3
Apex considered
5.0 175.9 178.3,127.9,104.2 94.5, 90.7, 85.8 304.4 43.8
Geometric optimization – dose prescription at 5mm
2.5 264.1 274.5, 235.8, 189.9 95.0, 89.7, 83.8 461.2 82.2
Apex not considered
5.0 284.5 295.5, 199.9, 162.8 95.9,91.2,85.8 470.6 85.3
2.5 215.9 226.7, 173.9,148.5 86.9, 82.2, 76.8 422.4 72.6
Apex considered
5.0 246.2 261.1, 176.6, 143.8 84.7, 80.6, 75.8 415.7 70.8
Table 4. Evaluated parameters for vaginal cylinder of 3.5cm diameter.
Dose Point* – Dose specifi cation points placed on the lateral sides of the vaginal cylinder.
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Dose Specification/Optimization Points: 
Considering the apex point for dose speciﬁ cation 
reduces dose to apex as well as at the curved por-
tion of the cylinder, and it is more pronounced 
with DPO than GO (see Tables 1–4).
Effect of Distal Dwell Position: Skipping the dis-
tal dwell position reduces the dose to apex, and 
shrinks the prescription isodose. Table 7 shows 
dose to apex with and without distal dwell position 
for dose prescription at surface and at 5mm and 
without considering apex for optimization.
Dose to Organ at Risk: Distal dwell position, dose 
prescription depth and mode of optimization in-
ﬂ uence the dose to bladder and rectum.
Skipping the distal dwell position and dose pre-
scription on the surface of the cylinder reduces 
dose to rectum and bladder in the studied pa-
tients, as shown in Table 8 and Table 9. Dose to 
rectum and bladder is less for GO than DPO. For 
DPO mean bladder dose with and without distal 
dwell position is 84.2% and 74.3% and for GPO 
75.7% and 66.6% respectively. For DPO mean 
rectal dose with and without distal dwell posi-
tion is 68.4% and 66.9% and for GPO 67.3% and 
65.9% respectively.
DISCUSSION
PLATO brachytherapy software offers the choice 
to place dose points for dose prescription at a de-
sired depth from the centre of the vaginal appli-
cator. The simplest and fastest way to perform 
optimization for a single straight catheter is to 
use DPO or GO on dose points placed at a de-
sired depth along the catheter. The inﬂ uence of 
various HDR parameters and optimization tech-
nique on the dose distribution of HDR vaginal 
Diameter of the cylinder – 2.0cm Diameter of the cylinder – 2.5cm 
Step 
size 
(mm)
Mode of 
optimization
Dose at apex % increase 
in apex 
dose
Dose at apex % increase 
in apex 
dose
For
optimiatizationPrescription
at surface
Prescription
at 5mm
Prescription
at surface
Prescription
at 5mm
2.5
DPO 122.0 208.8 71.1 148.8 239.6 61.0
Apex not considered
GO 104.8 159.2 51.9 111.8 179.6 60.7
2.5
DPO 103.5 106.2 2.7 104.5 106.6 2.0
Apex considered
GO 104.4 154.0 47.5 111.0 172.1 55.0
5.0
DPO 127.9 225.1 76.0 156.8 243.9 55.5
Apex not considered
GO 116.9 205.1 75.5 143.1 229.0 60.0
5.0
DPO 105.2 112.1 6.6 109.6 118.2 7.8
Apex considered
GO 116.2 193.7 66.7 139.5 213.7 53.2
Diameter of the cylinder – 3.0 cm Diameter of the cylinder – 3.5 cm
Step 
size 
(mm)
Mode of 
optimization
Dose at apex % increase 
in apex 
dose
Dose at apex % increase 
in apex 
dose
For
optimiatizationPrescription
at surface
Prescription
at 5mm
Prescription
at surface
Prescription
at 5mm
2.5
DPO 194.0 280.3 44.5 213.9 294 37.4
Apex not considered
GO 147.2 223.1 51.6 172.8 264.1 52.8
2.5
DPO 105.5 117 10.9 107.6 117.4 9.1
Apex considered
GO 143.6 208.8 45.4 161.3 215.9 33.8
5.0
DPO 203.0 297.9 46.7 216.5 305 40.9
Apex not considered
GO 190.4 278.6 46.3 191.4 284.5 48.6
5.0
DPO 111.7 122.7 9.8 113.1 124.6 10.2
Apex considered
GO 175.1 258.0 47.3 175.9 246.2 40.0
Table 5. Eff ect of prescription depth on dose to apex – NCDM.
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Table 6. Length of prescription isodose (in cms) – NCDM.
Step 
size 
(mm)
Mode of 
optimization
Diameter of Vaginal cylinder (2.0cm) Diameter of Vaginal cylinder (2.5cm)
For
optimiatizationDose prescription 
at surface
Dose prescription 
at 5mm 
Dose prescription 
at surface
Dose prescription 
at 5mm 
2.5
DPO 5.4 5.85 5.65 6.1
Apex not considered
GO 5.2 5.55 5.6 5.8
2.5
DPO 5.4 5.6 5.5 5.75
Apex considered
GO 5.2 5.5 5.4 5.7
5.0
DPO 5.5 5.85 5.65 6.1
Apex not considered
GO 5.45 5.8 5.6 6.0
5.0
DPO 5.4 5.7 5.5 5.8
Apex considered
GO 5.35 5.6 5.4 5.75
Step 
size 
(mm)
Mode of 
optimization
Diameter of Vaginal cylinder (3.0cm) Diameter of Vaginal cylinder (3.5cm)
For
optimiatizationDose prescription 
at surface
Dose prescription 
at 5mm 
Dose prescription 
at surface
Dose prescription 
at 5mm 
2.5
DPO 5.8 6.4 6.1 6.6
Apex not considered
GO 5.7 6.05 5.8 6.3
2.5
DPO 5.6 5.9 5.75 6.15
Apex considered
GO 5.5 5.8 5.7 6.0
5.0
DPO 5.85 6.4 6.2 6.5
Apex not considered
GO 5.8 6.2 6.1 6.4
5.0
DPO 5.7 6.1 5.95 6.3
Apex considered
GO 5.6 5.8 5.7 6.0
Table 7. Eff ect of Distal Dwell Position (DDP*) on Dose to Apex** (NCDM – 5mm stepsize).
Diameter of 
the cylinder 
(cm)
Mode of 
optimization
Dose prescription at surface % decrease 
in dose to 
apex
Dose prescription at 5mm % decrease 
in dose to 
apexWith DDP Without DDP With DDP Without DDP
2.0
DPO 127.9 75.4 69.6 225.1 128.7 74.9
GO 116.9 65.0 79.8 205.1 112.7 82.0
2.5
DPO 156.8 93.4 67.9 243.9 139.8 74.5
GO 143.1 80.5 77.8 229.0 130.0 76.1
3.0
DPO 203.0 114.7 77.0 297.9 158.6 87.8
GO 190.4 104.0 83.1 278.6 160.7 73.4
3.5
DPO 216.5 129.3 67.4 305.0 162.7 87.5
GO 191.4 120.8 58.4 284.5 176.0 61.6
* Distal Dwell Position; Dose to Apex** – Apex Not considered for dose prescription and optimization.
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cylinder models (CDM and NCDM) was elabo-
rately studied.
Parameters such as number of source dwell po-
sition, dwell position, choice of dose prescrip-
tion depth and optimization choice inﬂ uence 
the dose distribution and offer scope to reduce 
the dose to organs in close proximity to the vag-
inal cylinder in vaginal cuff irradiation.
Though the CDM with DPO gives more uniform 
dose over the dome region, the shape of the pre-
scription isodose in the dome region is constricted 
laterally as compared with the NCDM (Figure 3A 
CDM and Figure 3B NCDM). Although the apex 
of the vagina has high radiation tolerance, the 
overlying bowel receives a signiﬁ cant radiation 
dose, as it is proximal to the apex of the vaginal 
cylinder. Our study shows that in NCDM the dose 
to the apex increases when the apex is not con-
sidered for dose speciﬁ cation, leading to delivery 
of a signiﬁ cant dose to the overlying small bowel. 
However, in the NCDM, dose to apex and dome 
points are less when the apex is not considered 
for dose speciﬁ cation in GO compared to DPO. 
Thus optimization technique also inﬂ uences the 
Table 8. Infl uence of Distal Dwell Position and Optimization on Bladder Dose.
Patient 
number
Cylinder 
diameter 
(cms)
Intended 
treatment 
length
(cms)
Bladder dose (%)
Percentage increase in 
Bladder Dose with Distal 
Dwell Point
With distal Dwell
source position
Without distal Dwell
source position
Dose point 
optimization
Geometric 
optimization
Dose
point 
optimization
Geometric 
optimization
% decrease 
in the
dose 
Dose
point 
optimization
Geometric 
optimization
% decrease 
in the
dose 
% increase 
in the
dose 
% increase 
in the
dose 
1 3 8 125.0 109.0 12.8 105.0 92.0 12.4 19.0 18.5
2 3.5 7.5 94.0 85.0 9.6 87.0 78.0 10.3 8.0 9.0
3 3.5 7 98.8 88.1 10.8 82.4 73.8 10.4 19.9 19.4
4 3.5 8 90.1 81.7 9.3 80.0 73.0 8.8 12.6 12.0
5 3.5 5.75 48.8 45.0 7.8 40.0 36.5 8.8 22.0 23.3
6 3.5 7.5 140.6 123.4 12.2 121.6 106.8 12.2 15.6 15.5
7 3.5 6.5 80.3 76.5 4.7 74.6 70.4 5.6 7.6 8.7
8 3 6.5 114.0 104.0 8.8 105.0 93.2 11.2 8.6 11.6
9 3 7 112.8 98.8 12.4 84.5 74.9 11.4 33.5 31.9
10 3 6.75 84.3 73.5 12.8 81.0 70.5 13.0 4.1 4.3
11 3 9.5 79.9 71.5 10.5 71.0 63.0 11.3 12.5 13.5
12 3 7 67.7 62.0 8.4 62.0 57.0 8.1 9.2 8.8
13 3 7 79.8 71.7 10.2 66.7 59.6 10.6 19.6 20.3
14 3 9 55.8 51.0 8.6 52.0 47.3 9.0 7.3 7.8
15 3 10 119.0 102.0 14.3 103.0 87.8 14.8 15.5 16.2
16 2 9.5 37.5 34.0 9.3 34.0 31.0 8.8 10.3 9.7
17 3.5 10 73.0 66.2 9.3 65.0 58.6 9.8 12.3 13.0
18 3 8 76.6 70.9 7.4 72.0 65.4 9.2 6.4 8.4
19 3 10 41.2 38.0 7.8 39.7 37.0 6.8 3.8 2.7
20 3 7 65.0 61.2 5.8 60.4 57.2 5.3 7.6 7.0
Mean dose in % 84.2 75.7  74.3 66.6  
Standard deviation 28.2 24.0  23.3 19.8  
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dose to the apex and dome region of the vaginal 
cylinder. Inﬂ uence of optimization technique on 
the shape of the prescription isodose is illustrat-
ed in Figure 4A (dose point optimization) and 
Figure 4B (geometric optimization)
Dose on the ﬁ rst dome point is always higher than 
on the apex and dose points. Higher dose value at 
the ﬁ rst dome point may be attributed to the fact 
that the dome point lies closer to the ﬁ rst dwell po-
sition of the source than the dose points that lie at 
a distance equal to the radius of the applicator.
Change in dose prescription depth from the sur-
face of the applicator to 5mm depth results in a 
high dose to apex and dome points in the studied 
vaginal cylinders. The American Brachytherapy 
Society (ABS) suggests treating only the upper half 
of the vagina [6]. Irradiated length by HDR brach-
ytherapy source is higher than the physical source 
loading length. Our study shows that source load-
ing length of 4 cm gives a prescription isodose 
enclosing a length between 5.5cm and 6.6cm for 
dose prescription depth of 5mm depending on 
the diameter of the cylinder , optimization tech-
Table 9. Infl uence of distal Dwell position and optimization on rectal dose.
Patient 
number
Cylinder 
diameter 
(cms)
Intended 
treatment 
length
(cms)
Rectal dose (%)
Percentage increase in 
rectum dose with distal 
Dwell point
With distal Dwell
source position
Without distal Dwell
source position
Dose
point 
pptimization
Geometric 
optimization
Dose
point 
optimization
Geometric 
optimization
% decrease 
in the
dose 
Dose
point 
optimization
Geometric 
optimization
% decrease 
in the
dose 
% increase 
in the
dose 
% increase 
in the
dose 
1 3 8 80.0 79.2 1.0 79.4 78.6 1.0 0.8 0.8
2 3.5 7.5 58.0 57.3 1.2 56.1 55.2 1.6 3.4 3.8
3 3.5 7 52.5 51.8 1.3 51.8 51.2 1.2 1.4 1.2
4 3.5 8 58.2 57.0 2.1 57.2 55.3 3.3 1.7 3.1
5 3.5 5.75 68.9 68.1 1.2 68.2 67.4 1.2 1.0 1.0
6 3.5 7.5 68.3 67.4 1.3 67.9 67.1 1.2 0.6 0.4
7 3.5 6.5 87.6 86.0 1.8 83.6 81.8 2.2 4.8 5.1
8 3 6.5 70.0 67.3 3.9 67.3 66.8 0.7 4.0 0.7
9 3 7 57.8 57.4 0.7 55.4 54.6 1.4 4.3 5.1
10 3 6.75 76.3 74.2 2.8 75.2 73.9 1.7 1.5 0.4
11 3 9.5 68.3 67.9 0.6 67.6 67.2 0.6 1.0 1.0
12 3 7 77.4 76.2 1.6 76.8 75.2 2.1 0.8 1.3
13 3 7 70.3 69.4 1.3 68.6 68.2 0.6 2.5 1.8
14 3 9 77.4 75.6 2.3 72.8 72.4 0.5 6.3 4.4
15 3 10 63.0 62.2 1.3 62.0 61.0 1.6 1.6 2.0
16 2 9.5 52.5 51.8 1.3 51.4 50.7 1.4 2.1 2.2
17 3.5 10 90.5 90.0 0.6 89.7 89.1 0.7 0.9 1.0
18 3 8 72.0 70.3 2.4 71.6 69.0 3.6 0.6 1.9
19 3 10 54.7 54.0 1.3 53.2 52.0 2.3 2.8 3.8
20 3 7 64 63.1 1.4 62.8 61.5 2.1 1.9 2.6
Mean dose in% 68.4 67.3  66.9 65.9  
Standard deviation 11.0 10.8  10.8 10.8  
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Figure 3. Illustration of shape of prescription isodose line for CDM and NCDM vaginal cylinder. (A) Curved Dome Model (CDM). (Vaginal 
cylinder diameter – 3.0cm, dose prescription on the surface, step size – 5mm. Apex point excluded for dose prescription, dose point 
optimization). Dose points for dose prescription. (B) Non-Curved Dome Model (NCDM). (Vaginal cylinder diameter – 3.0cm, dose prescription 
on the surface, step size – 5mm, apex point excluded for dose prescription, dose point optimization]. Dose points for dose prescription.
BA
Figure 4. Illustration of infl uence of optimization technique on the shape of the prescription isodose line. (A) Non-Curved Dome Model 
(NCDM), Dose point optimization. Vaginal cylinder diameter – 3.0cm, dose prescription on the surface, step size – 5mm. (B) Non-Curved 
Dome Model (NCDM). Geometric optimization. Vaginal cylinder diameter – 3.0cm, dose prescription on the surface, step size – 5mm.
BA
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nique and dose speciﬁ cation points. Considering 
the apex for dose speciﬁ cation reduces the length 
of the enclosing prescription isodose to 5mm in 
3cm and 3.5cm diameter vaginal cylinder for dose 
point optimization. Figure 5 illustrates the inﬂ u-
ence of apex point for dose prescription on the 
length of the prescription isodose for NCDM. 
Thus it is clear from our study that if the source 
loading length is kept the same as that of the in-
tended treatment length, a higher dose to both 
apex and lower part of the vagina will be delivered. 
Skipping the distal dwell position brings the isod-
ose line closer to the apex of the cylinder and re-
duces the dose to the apex, rectum and bladder. 
Inﬂ uence of skipping distal dwell position on the 
Figure 5. Illustration of shape of the prescription isodose line 
(superimposed) with and without considering apex for dose 
prescription (geometric optimization). Non-Curved Dome 
Model. Vaginal cylinder diameter – 3.5cm, step size – 5mm, 
dose prescription at 5mm from the surface. — Red prescription 
isodose line – without apex point for dose prescription. — Green 
prescription isodose line – with apex point for dose prescription.
Figure 6. Illustration of infl uence of distal dwell position on 
the length of prescription isodose line (superimposed). (A) Non-
Curved Dome Model. Dose point optimization. Vaginal cylinder 
diameter – 3.0cm, step size – 5mm, dose prescription on the 
surface. Red prescription isodose line – with distal dwell position. 
Green prescription isodose line – without distal dwell position. 
(B) Non-Curved Dome Model. Geometric optimization. Vaginal 
cylinder diameter – 3.0cm, step size – 5mm, dose prescription 
on the surface. — Red prescription isodose line – with distal 
dwell position. — Green prescription isodose line – without 
distal dwell position. 
B
A
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length of the prescription isodose is illustrated in 
Figure 6A (dose point optimization) and Figure 
6B (geometric optimization). However, dose pre-
scription depth on the surface of the cylinder 
without distal dwell position for 2cm and 2.5cm 
vaginal cylinder reduces the length of the prescrip-
tion isodose and brings it well below the apex, re-
sulting in a dose to the apex lower than the pre-
scribed dose. Depending on the diameter of the 
vaginal cylinder and dose speciﬁ cation depth, the 
most distal and two dwell positions on the proxi-
mal side can be removed to reduce dose at apex 
and to lower vaginal mucosa. In estimating the 
bladder dose, a reference point on the posterior 
part of the bladder alone is considered. The var-
iation in the reduction of dose may be attributed 
to the difference in the distance between bladder 
point and the applicator. From the studied HDR 
patients, though skipping distal dwell position re-
duces the dose to the rectum and bladder, the de-
cision should be taken by the clinician. American 
Brachytherapy Society guidelines on HDR treat-
ment for endometrial carcinoma suggest that a 
pre-calculated treatment plan can be used for pa-
tient treatment delivery. However, the disadvan-
tage with using a standard plan is that the dose 
to OAR cannot be computed.
CONCLUSIONS 
HDR parameters inﬂ uencing the dose distribu-
tion around the vaginal cylinders are identiﬁ ed. 
By appropriately selecting the parameters, the 
dose to the apex of the vaginal cylinder can be re-
duced in vaginal cuff irradiation, which helps to 
minimize the dose to the small bowel. Choice of 
optimization and dose speciﬁ cation points affects 
rectal and bladder dose. CDM with dose point 
optimization results in more uniform dose distri-
bution around the vaginal cylinder than NCDM. 
Apex point needs to be considered for dose pre-
scription and optimization to obtain a uniform 
dose. Dose distribution for all the vaginal cylin-
ders can be stored as a library plan and the best 
matched dose distribution according to the tar-
get geometry can be used for treatment.
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